These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18217408)

  • 1. Are elevated serum levels of IGFBP-2 after intensive chemotherapy of childhood acute lymphoblastic leukemia a risk factor of relapse?
    Kitszel A; Krawczuk-Rybak M
    Adv Med Sci; 2007; 52():147-53. PubMed ID: 18217408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children.
    Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S
    Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors].
    Mohnike K; Kluba U; Blum WF; Aumann V; Vorwerk P; Mittler U
    Klin Padiatr; 1995; 207(4):225-9. PubMed ID: 7564158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML.
    Dawczynski K; Kauf E; Schlenvoigt D; Gruhn B; Fuchs D; Zintl F
    Bone Marrow Transplant; 2006 Mar; 37(6):589-94. PubMed ID: 16444283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in concentrations of circulating insulin-like growth factors I and II and binding proteins BP-2 and BP-3 in children treated for acute lymphoblastic leukaemia].
    Krawczuk-Rybak M; Kitszel A; Wołczyński S
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):15-20. PubMed ID: 15355735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein (IGFBP-2) in children with acute lymphoblastic leukemia.
    Riikonen R; Vettenranta K; Riikonen P; Turpeinen U; Saarinen-Pihkala UM
    Pediatr Blood Cancer; 2004 Aug; 43(2):110-4. PubMed ID: 15236275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor binding protein-2 at diagnosis of childhood acute lymphoblastic leukemia and the prediction of relapse risk.
    Vorwerk P; Mohnike K; Wex H; Röhl FW; Zimmermann M; Blum WF; Mittler U
    J Clin Endocrinol Metab; 2005 May; 90(5):3022-7. PubMed ID: 15687344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor system in Egyptian children with acute lymphoblastic leukemia.
    Zakhary NI; Boshra SA; El-Sawalhi MM; Fahim AT; Ebeid EN
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1067-72. PubMed ID: 22853046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of serum growth factors (IGF-I,-II and IGFBP-2,-3) prior to and after stem cell transplantation in children with acute leukemia.
    Dawczynski K; Kauf E; Zintl F
    Bone Marrow Transplant; 2003 Aug; 32(4):411-5. PubMed ID: 12900778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.
    Mohnike KL; Kluba U; Mittler U; Aumann V; Vorwerk P; Blum WF
    Eur J Pediatr; 1996 Feb; 155(2):81-6. PubMed ID: 8775218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of components of the IGF axis in childhood acute myelogenous leukemia.
    Dawczynski K; Steinbach D; Wittig S; Pfaffendorf N; Kauf E; Zintl F
    Pediatr Blood Cancer; 2008 Jan; 50(1):24-8. PubMed ID: 17635002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B; Kural N; Colak O; Ak I; Akcar N
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone.
    Wex H; Vorwerk P; Mohnike K; Bretschneider D; Kluba U; Aumann V; Blum WF; Mittler U
    Br J Cancer; 1998 Aug; 78(4):515-20. PubMed ID: 9716037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
    Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
    Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
    Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of tau protein in children treated for acute lymphoblastic leukemia.
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
    Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.